FMP

FMP

Enter

RXST - RxSight, Inc.

Financial Summary of RxSight, Inc.(RXST), RxSight, Inc., a medical technology company, engages in the research and development, manufacture, a

photo-url-https://financialmodelingprep.com/image-stock/RXST.png

RxSight, Inc.

RXST

NASDAQ

RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

51.58 USD

-0.17 (-0.33%)

About

ceo

Dr. Ronald M. Kurtz M.D.

sector

Healthcare

industry

Medical - Devices

website

https://www.rxsight.com

exchange

NASDAQ

Description

RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. ...

CIK

0001111485

ISIN

US78349D1072

CUSIP

78349D107

Address

100 Columbia

Phone

949 521 7830

Country

US

Employee

374

IPO Date

Jul 30, 2021

Summary

CIK

0001111485

Exchange

NASDAQ

Industry

Medical - Devices

Sector

Healthcare

CUSIP

78349D107

ISIN

US78349D1072

Country

US

Price

51.58

Beta

1.22

Volume Avg.

408.2k

Market Cap

1.91B

Shares

-

52-Week

17.0-58.21

DCF

0

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-36.58

P/B

-

Website

https://www.rxsight.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest RXST News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep